Objective: Despite a growing call to use patient-reported outcomes (PRO) in clinical research, few are available for measuring upper limb function post-stroke. We examined the Disabilities of the Arm, Shoulder and Hand (DASH) to evaluate its measurement performance in acute stroke. In doing so, we compared results from traditional and modern psychometric methods. 
INTRODUCTION
Approximately 70-80% of people with acute stroke have upper limb dysfunction. [1, 2] This can affect a person's ability to perform activities of daily living (ADLs), including self-care, leisure, work and social activities, and impacts on levels of independence. [3] Therefore, recovery of upper limb function is often a primary goal for rehabilitation following stroke. [4, 5] It is commonly assessed using clinician-rated or performance outcome measures (ClinROs, PerFOs) including the Box and Block Test [6] and the Action Research Arm Test. [7] One goal of patient-reported outcome (PRO) measures is to quantify the activity and participation restrictions that arise from impairments in order to examine their impact on individuals' daily lives and evaluate their treatments. [5, 8] However, despite a growing call to include PRO measures in clinical research including stroke, [9] [10] [11] few upper limb PRO measures have been used in acute stroke. [3, 5] The Disabilities of the Arm, Shoulder and Hand (DASH) is a PRO instrument purporting to measure physical function and symptoms in people with upper limb disorders. [12] Originally developed for use in orthopaedic populations, [12] it is one of the most widely used upper limb rating scales. [13, 14] Its psychometric properties have been extensively evaluated in musculoskeletal disorders; [3] however, there are no published psychometric evaluations of the DASH in stroke. [3, 15] The widespread use of the DASH underpinned our evaluation in people with acute stroke to examine its suitability as an outcome measure. We used two psychometric paradigms: traditional psychometric methods based on Classical Test Theory (CTT) [16] and modern psychometric methods based on Rasch Measurement Theory (RMT). [17] There were two aims: to evaluate the measurement properties of the DASH in people with acute stroke; and, to compare and contrast CTT with RMT.
METHODS

Participants, recruitment and data collection
This is a pooled sample of three subgroups of people in the early post-stroke period. People 
PRO Instruments
The DASH has 30 items aiming to measure physical function and symptoms in people with upper limb disorders. [12] Items are scored from 1 (no difficulty) to 5 (unable), summed to generate a total 'disability/symptom' score, and averaged to produce a mean item score between 1 and 5. This value is transformed to a score out of 100 by subtracting one and multiplying by 25. A higher score indicates greater disability.
Analysis Plans
We used the approach some of us had taken in examining the DASH in multiple sclerosis (MS). [18] Specifically, we compared and contrasted psychometric evaluations using CTT [16] and RMT. [17] Traditional psychometric (CTT) methods CTT methods examined five psychometric properties of the DASH, the statistical methods and associated criteria are documented fully elsewhere. [18] [19] [20] [21] [22] [23] [24] [25] [26] Specifically and in brief, we examined DASH data against published criteria for: (1) data completeness (percent missing data for each item[21]); (2) scaling assumptions (similarity of item means and variances, magnitude and similarity of corrected item-total correlations [19] [20] [21] [22] ); (3) scale-to-sample targeting (score means, standard deviation (SD), floor and ceiling effects [23, 24] ); (4) internal consistency reliability (Cronbach's alpha;[25] mean inter-item correlation [26] ); and (5) responsiveness, examined by comparing baseline and 6-week scores (effect size and standardized response mean). Data analyses were conducted using SPSS (version 19.0).
Rasch Measurement Theory (RMT) methods
In RMT, the degree to which measurements can be derived from item responses is evaluated using a single mathematical equation, the Rasch model, which defines how a set of items should perform in order to generate reliable and valid measurements. [17, 27, 28] RMT is explained for clinicians elsewhere. [29] Briefly, RMT examines the extent to which the observed scores (person responses) 'fit' the expected values predicted by the Rasch model, indicating the degree to which rigorous measurement is achieved. RMT analyses were grouped into three areas: scale-to-sample targeting, scale performance and person measurement. The methods and associated criteria are documented fully elsewhere. [18, 27, [29] [30] [31] [32] Data analyses were conducted using RUMM2030. [33] 
RESULTS
Sample
The sample (n=172) included: 125 people admitted to the HASU, 34 people admitted to the ARU, and 13 people admitted to the NRU (Table 1) . People with upper limb impairments, as identified from clinical assessment, completed the DASH 6 weeks later (n=99;
Supplementary Table I) . Therefore, data from 271 questionnaires were stacked for analysis. [29] At baseline, the sample mean age was 61 years (range 18-75), mean time poststroke was 3 weeks (range 1-12) and 41% were women (Table 1) .
Traditional psychometric (CTT) methods
The results of CTT analyses supported the DASH as a reliable and valid measure of upper limb function in stroke. In summary, traditional psychometric criteria were satisfied for all measurement properties evaluated (data completeness, scaling assumptions, targeting, reliability, responsiveness; Table 2 ). Table 2 shows that data completeness was high: there were no item-level missing data, and scale scores were computable for all respondents.
Data completeness
Scaling assumptions
Criteria for scaling assumptions were satisfied: items had similar mean scores and variances, and all corrected item-total correlations exceeded 0.30 (Table 2 ).
Targeting DASH scores spanned 88% of the scale range and were not notably skewed. There was no floor effect but a ceiling effect of 14.4%, below the recommended 20% maximum ( Table   2 ). [23, 24] Reliability Internal consistency reliability was very, perhaps surprisingly, high (Cronbach's alpha=0.99) and the mean inter-item correlation (0.70) exceeded the recommended minimum of 0.30 (Table 2 ). The 95% confidence interval around DASH scores was ±5.25 points.
Responsiveness
The mean change in scores for the subsample of people who completed the DASH again at 6 weeks (n=99) was 12.4pts (SD 17.7; Table 2 ). This group-level improvement was statistically significant and clinically moderate according to Cohen's criteria. [34] Rasch Measurement Theory (RMT) methods RMT analyses were more informative than those from CTT. As some item response categories had not been endorsed we invoked the null category adjustment feature available in RUMM2030. [35] Scale-to-sample targeting Scale-to-sample targeting was suboptimal. Figure 1 shows that the sample appears reasonable for examining scale performance: the sample covers the item locations. However, the scale does not cover the sample: a number of people are not covered by the items and the ceiling effect is notable.
Scale performance
Did the item response categories work as intended?
Thresholds were disordered for 4/30 items implying that the 5-category scoring function was not working as intended for these items (Table 4 
What continuum was mapped out by the items?
Item locations ranged from −1.61 to +1.78 logits, item thresholds from −3.95 to +3.59 logits, indicating the items mapped out a measurement continuum (Table 3) . However, there was limited spread and items were bunched at points along the continuum (Figure 1 ).
To what extent did the items work together?
Sixteen items had fit residuals outside the recommended range (−2.5 to +2.5), one notably so ('feeling less capable', +12.39), and eight items had significant chi-square values (Table 4) .
Examinations of the graphical indictor of fit (ICC) showed that most items displayed reasonable visual fit despite statistical misfit. However, ICCs for three items suggested they were under-discriminating: 'write', 'sexual activities' and 'feeling less capable' (Supplementary Figure II) .
To what extent did the response to one item bias the response to another?
Sixty-five pairs of items had residual correlations exceeding the criteria of <0.30 (15% of total correlations) implying that a response to one item influenced the response to the other item. Three pairs of items correlated highly (>0.60): 'do heavy household chores' with 'garden' (0.63); 'recreational activities: force/impact' with 'recreational activities: move arm freely' (0.80); and 'pain' with 'pain performing an activity' (0.87).
Person measurement
Person measures covered a wide range (−6.65 to +2.90 logits) and the Person Separation Index (PSI=0.96) implied good sample separation and high reliability (Table 3) . However, 84
person fit residuals (range −5.85 to +5.00) exceeded the recommended range (−2.5 to +2. 5) implying that approximately 36% of people gave responses not in keeping with expectation. Table 3 shows that group-level responsiveness analyses recorded a significant improvement at 6 weeks post-stroke, clinically mild-to-moderate according to Cohen's criteria. [34] At the individual person level, 51% had a statistically significant improvement and a further 30% made a non-significant improvement.
DISCUSSION
Our aim was to evaluate the measurement performance of the DASH in a sample of people early post-stroke. Traditional psychometric methods implied that the DASH was reliable and valid. Our findings were similar to our CTT examination of the DASH in MS [18] and supported the summing of item scores into a single upper limb symptom/disability score.
However, RMT analysis provided more sophisticated information and raised concerns about the DASH as an outcome measure in acute stroke.
RMT analyses revealed that, for four items, the scoring function did not work as intended.
One explanation is that there are too many response categories for people to reliably choose between. This finding is consistent with our previous study in MS. [18] Another explanation arises from the sub-optimal targeting. For the pain items, there were not enough people located at the more disabled end of the continuum to infer confidently that threshold disordering exists. RMT analyses identify problems; they do not indicate the cause. Exploring possible reasons for the disordering is important as ordered thresholds are necessary for scale validity. [30, 36] Over 50% of items had statistical misfit implying that the items were not as statistically cohesive as required for deriving measurements from an item set. Item misfit has many possible causes, including disordered thresholds. However, misfit may arise from the content of the item set. The DASH has items measuring physical function, symptoms and social participation. Previously, we suggested the DASH is capturing a broader construct, not simply upper limb functioning. [18] From a measurement perspective, combining symptoms with functioning threatens scale validity. From a clinical perspective, this means that DASH scores lack meaning and interpretability.
The hierarchical ordering of the DASH items suggests, from a clinical perspective, that the scale items represent more than one dimension (multidimensionality). Examination of the item locations in Table 4 reveals that the item ordering is not intuitive clinically. We explored this further by combining the items into four clinically sensible groups -symptoms (items [24] [25] [26] [27] [28] [29] , participation (items 17-23, 30), dexterity (items 1-4, 15, 16) and power/range of motion (items 5-14) -and performing exploratory subtest analyses. Subtest analyses are performed post-hoc and can be used to explore the presence of multidimensionality within a scale. Perhaps counterintuitively, traditional reliability indicators can be over-inflated by multidimensionality, in part because they are not indicators of unidimensionality as is mistakenly thought. [31] In a subtest analysis, items are grouped into 'subtests' which are then treated by the analysis as single 'super' items. So here, the four item groups or 'subtests' are analysed as if they were a four-item scale. If reliability indicators (e.g. PSI and alpha) fall, multidimensionality is implied. We found that the PSI dropped from 0.96 to 0.87 (alpha dropped from 0.99 to 0.92) implying that DASH reliability was artificially inflated, supporting our clinical impression of multidimensionality. However, this issue is not simple because a fall in reliability indicators following subtest analysis can also occur when there is item response bias (local dependence). Also, alpha values are dependent on the number of extreme scores (here a notable amount) and item-item correlations (here very high). We would stress that this issue is complex and a full discussion and examination beyond the scope of this manuscript, and refer interested readers to other sources. [31, 32] As highlighted above, reliability indicators can also be inflated by local dependence among items, or item response bias. [31] We found 65 pairs of items with residual correlations >0.30 and three pairs of items which correlated highly (>0.60) suggesting local dependency. All three pairs of highly correlated items appear sequentially in the DASH and have similar content, implying that this dependency may be due to an ordering and/or content effect.
Targeting is worthy of particular attention when a scale is being used outside its original context area, and sub-optimal targeting has important implications. An added advantage of RMT is the graphical targeting illustration: the match between item locations and person locations (Figure 1) . Here, the measurement of people with mild upper limb dysfunction is limited, and the ceiling effect indicates that a notable proportion of people had no measured upper limb dysfunction post-stroke. Therefore, despite satisfying published criteria, [23, 24] the ceiling effect represents a cohort of the sample for whom changes within people and differences between people will be underestimated. [37] This has implications for endpoint measurement and selection of outcome measures early post-stroke.
When selecting endpoint measures, scales should be targeted to clinical settings as well as the sample. Therefore, an important consideration is the nature of the items in relation to the intended context of use. For example, sixteen DASH items concern activities of daily living (ADLs) which are potentially difficult for people to report meaningfully within acute settings.
People may have guessed their abilities which could explain the high ability findings in a disorder where upper limb dysfunction is common. Guessing could also account for the high number of misfitting persons detected by RMT analyses compared to those found in MS (stroke=36%; MS=8%). [18] Cognitive impairment can affect performance of PROs, causing person misfit, and is an important factor to consider early post-stroke. We did not formally assess cognitive status; instead a clinical judgement was made on whether the person was suitable for inclusion or not based on informal screening by a research nurse. We acknowledge this is a limitation but it is difficult to determine the exact cut-off score on a cognitive test which would indicate the point at which a person was able to give valid responses on a PRO. This area is complex and requires further investigation. Rasch measurement methods profile individual person response patterns which can allude to the presence of cognitive impairment, especially if responses are way out of keeping. However, despite notable levels of disability, person fit was better in MS (a condition in which cognition is affected) than in stroke (8% vs 36% misfit) as outlined above. This lends support to our suggestion that misfit may have been due to people guessing their abilities within a context where they were unable to perform many of the ADLs included in the DASH.
Responsiveness analyses showed that the DASH recorded improvements in the subsample of people who had upper limb impairments (n=99; see Supplementary Table I for sample characteristics). RMT methods are able to go beyond CTT methods of group-level responsiveness testing and examine individual person-level change (Table 3) . Our results are in keeping with clinical expectation of early post-stroke recovery. However, a proportion of people did get worse, some significantly. One explanation is that, during recovery, some people may have become more aware of their limitations and difficulties, and provided more accurate reporting at the 6-week follow-up. Further work is required to examine these individual's responses and help explain anomalies.
A limitation of this study is that the DASH was administered to patients admitted to the hyper-acute stroke unit regardless of whether any upper limb impairment existed or not. This is because a pre-determined battery of measures was administered. However, it highlights the need for careful consideration of instrument selection and patient recruitment to ensure appropriate scales are targeted to appropriate people.
A further limitation is that we did not undertake standard validity testing. However, correlations with other measures provide circumstantial validity evidence only and would have added little to our findings. [38, 39] Nevertheless, comparison of subgroups with and without upper limb impairment provides some evidence of validity: mean DASH scores between the two subsamples were significantly different implying that the DASH could discriminate between groups known to differ in level of upper limb function (Supplementary   Tables I and II) .
One aim of our study was to compare and contrast two psychometric methods: CTT and RMT. CTT methods, based on weak measurement theory, [16, 29] are limited in their ability to provide detailed diagnostic item-and person-level examinations, and there is a lack of criteria against which to make judgements on scale and item performance. The existing arbitrary criteria of traditional methods are based on assumptions that cannot be tested formally. [29, 40] The added value of RMT is highlighted by the limitations identified: disordered response categories, item misfit and sub-optimal targeting. Importantly, RMT analyses provide the evidence-base for modifying and improving the DASH for future application in acute stroke research. Psychometric analysis plays a key role in scale development and testing: to ensure that scales provide scientifically robust, clinically meaningful and clinically interpretable measures. The sophisticated techniques of RMT can help to ensure that PRO instruments are robust measures of the health constructs they purport to quantify. Non-significant improvement, % (n) 29 (29) Non-significant worsening, % (n) 6 (6) Significant worsening, % (n) 7 ( 
